Adial Pharmaceuticals (ADIL) Short Interest Ratio & Short Volume $0.69 +0.00 (+0.54%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adial Pharmaceuticals Short Interest DataAdial Pharmaceuticals (ADIL) has a short interest of 217,100 shares, representing 3.36% of the float (the number of shares available for trading by the public). This marks a -47.99% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 975,037 shares to cover all short positions.Current Short Interest217,100 sharesPrevious Short Interest417,400 sharesChange Vs. Previous Month-47.99%Dollar Volume Sold Short$154,575.20Short Interest Ratio0.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares6,575,000 sharesFloat Size6,460,000 sharesShort Percent of Float3.36%Today's Trading Volume26,970 sharesAverage Trading Volume975,037 sharesToday's Volume Vs. Average3% Short Selling Adial Pharmaceuticals? Sign up to receive the latest short interest report for Adial Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADIL Short Interest Over TimeADIL Days to Cover Over TimeADIL Percentage of Float Shorted Over Time Adial Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025217,100 shares $154,575.20 -48.0%3.4%0.3 $0.71 3/31/2025417,400 shares $264,715.08 -24.0%6.5%0.5 $0.63 3/15/2025549,400 shares $381,228.66 -19.8%8.5%0.7 $0.69 2/28/2025685,300 shares $537,960.50 +610.2%10.6%0.8 $0.79 2/15/202596,500 shares $71,525.80 +59.2%1.5%0.1 $0.74 1/31/202560,600 shares $50,298.00 +195.6%1.0%0.3 $0.83 1/15/202520,500 shares $20,910.00 -9.3%0.3%0.1 $1.02 12/31/202422,600 shares $22,826.00 -60.8%0.4%0.1 $1.01 12/15/202457,600 shares $62,784.00 +16.4%0.9%0.3 $1.09 11/30/202449,500 shares $49,500.00 -71.7%0.8%0.3 $1.00 Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024175,000 shares $185,500.00 +121.8%2.8%1.2 $1.06 10/31/202478,900 shares $78,900.00 +54.1%1.3%0.6 $1.00 10/15/202451,200 shares $48,757.76 -34.2%0.8%0.2 $0.95 9/30/202477,800 shares $77,722.20 -47.0%1.2%0 $1.00 9/15/2024146,700 shares $158,436.00 -46.2%2.3%0.1 $1.08 8/31/2024272,800 shares $267,616.80 -14.5%4.3%0.1 $0.98 8/15/2024318,900 shares $309,045.99 +8.3%5.1%0.1 $0.97 7/31/2024294,400 shares $306,176.00 +92.5%7.2%0.1 $1.04 7/15/2024152,900 shares $169,719.00 -6.4%3.7%0.1 $1.11 6/30/2024163,300 shares $187,795.00 -25.2%4.0%0.1 $1.15 6/15/2024218,200 shares $285,842.00 +33.5%5.3%0.1 $1.31 5/31/2024163,400 shares $236,930.00 +23.5%4.0%0.1 $1.45 5/15/2024132,300 shares $187,866.00 -20.8%3.2%0 $1.42 4/30/2024167,100 shares $284,070.00 -83.5%4.4%0 $1.70 4/15/20241,010,000 shares $2.64 million +11,509.2%26.7%0.2 $2.61 3/31/20248,700 shares $11,571.00 -91.8%0.2%0 $1.33 3/15/2024105,600 shares $166,848.00 +275.8%7.0%0 $1.58 2/29/202428,100 shares $57,324.00 -83.8%1.9%0 $2.04 2/15/2024173,300 shares $201,028.00 +691.3%11.5%0.6 $1.16 1/31/202421,900 shares $24,968.19 -41.1%1.5%0.2 $1.14 1/15/202437,200 shares $53,984.64 +11.4%2.6%0.4 $1.45 12/31/202333,400 shares $62,124.00 +29.5%3.2%0.3 $1.86 12/15/202325,800 shares $45,150.00 -37.4%2.4%0.3 $1.75 11/30/202341,200 shares $90,228.00 -22.3%3.9%0.6 $2.19 11/15/202353,000 shares $112,360.00 -1.5%5.0%1.2 $2.12 10/31/202353,800 shares $103,834.00 +93.5%5.1%0.8 $1.93 10/15/202327,800 shares $77,006.00 -45.3%2.6%0.4 $2.77 9/30/202350,800 shares $141,218.92 +49.4%4.8%0.3 $2.78 9/15/202334,000 shares $99,620.00 -47.4%3.3%0.3 $2.93 8/31/202364,600 shares $282,948.00 -12.6%6.2%0.5 $4.38What President Trump’s Executive Order 14154 means for your money (Ad)Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi 8/15/202373,900 shares $283,916.41 +121.3%7.1%0.6 $3.84 7/31/202333,400 shares $268,035.00 -97.7%N/A0.3 $8.03 7/15/20231,430,000 shares $395,538.00 +3,084.9%N/A0.6 $0.28 6/30/202344,900 shares $9,348.18 -24.3%N/A0 $0.21 6/15/202359,300 shares $14,528.50 -36.4%N/A0.3 $0.25 5/31/202393,200 shares $24,511.60 -71.3%N/A0.3 $0.26 5/15/2023324,800 shares $104,812.96 -22.0%N/A0.5 $0.32 4/30/2023416,400 shares $143,449.80 +42.6%N/A0.6 $0.34 4/15/2023292,100 shares $87,045.80 -12.0%N/A0.4 $0.30 3/31/2023332,000 shares $116,200.00 -38.8%N/A0.5 $0.35 3/15/2023542,700 shares $201,884.40 +42.2%N/A0.8 $0.37 2/28/2023381,600 shares $167,904.00 +37.9%N/A0.6 $0.44 2/15/2023276,700 shares $102,655.70 +105.9%N/A1.1 $0.37 1/31/2023134,400 shares $63,168.00 -7.0%N/A0.6 $0.47 1/15/2023144,500 shares $46,254.45 +12.3%N/A1 $0.32 12/30/2022128,700 shares $27,670.50 -4.0%N/A1 $0.22 12/15/2022134,100 shares $32,572.89 +4.0%N/A1.4 $0.24 11/30/2022128,900 shares $34,789.98 -3.9%N/A1.3 $0.27 11/15/2022134,100 shares $39,438.81 -9.4%N/A0.9 $0.29 10/31/2022148,000 shares $43,660.00 -8.0%N/A0.9 $0.30 10/15/2022160,900 shares $52,614.30 -8.0%N/A0.6 $0.33 9/30/2022174,900 shares $61,215.00 -28.9%N/A0.3 $0.35 9/15/2022246,000 shares $119,777.40 -26.8%N/A0.3 $0.49 8/31/2022335,900 shares $180,311.12 +10.1%N/A0.4 $0.54 8/15/2022305,200 shares $181,594.00 -52.4%N/A0.4 $0.60 7/31/2022641,700 shares $417,105.00 -6.4%N/A0.9 $0.65 7/15/2022685,300 shares $1.12 million +17.9%N/A1.1 $1.63 6/30/2022581,500 shares $779,210.00 -27.4%N/A2.6 $1.34 6/15/2022801,200 shares $1.00 million -3.0%N/A4.7 $1.25 5/31/2022825,800 shares $1.04 million -4.8%N/A6.2 $1.26 5/15/2022867,100 shares $1.11 million +0.8%N/A7.6 $1.28 4/30/2022860,300 shares $1.21 million -8.3%N/A7.4 $1.41 4/15/2022938,000 shares $1.64 million +10.5%N/A7.8 $1.75 3/31/2022849,100 shares $1.71 million -2.1%N/A7.3 $2.01 3/15/2022867,000 shares $1.59 million +5.9%N/A7.4 $1.83 2/28/2022818,500 shares $1.69 million +8.3%N/A6.7 $2.06 2/15/2022755,600 shares $1.65 million +2.2%N/A5.1 $2.18 1/31/2022739,700 shares $1.54 million -9.0%4.3%4.3 $2.08 1/15/2022812,600 shares $2.13 million -5.7%4.7%4.1 $2.62 12/31/2021861,500 shares $2.33 million +1.1%5.0%3.8 $2.70 12/15/2021852,100 shares $2.29 million -9.5%4.9%3.1 $2.69 11/30/2021941,200 shares $2.62 million -5.5%5.6%3 $2.78 11/15/2021995,700 shares $3.15 million +13.7%5.9%2.6 $3.16 10/29/2021875,600 shares $2.81 million -11.0%5.3%1.9 $3.21 10/15/2021984,100 shares $3.82 million +3.4%6.0%2.1 $3.88 9/30/2021951,400 shares $4.08 million +10.3%5.8%1.6 $4.29 9/15/2021862,500 shares $3.54 million -3.0%5.3%1 $4.10 8/31/2021888,900 shares $3.64 million -10.0%5.6%0.7 $4.10 8/13/2021987,800 shares $3.24 million -9.4%6.0%0.8 $3.28 7/30/20211,090,000 shares $2.66 million +16.9%6.2%0.9 $2.44Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 7/15/2021932,600 shares $2.32 million -24.8%5.8%0.8 $2.49 6/30/20211,240,000 shares $3.16 million +103.0%7.9%1.2 $2.55 6/15/2021611,000 shares $1.65 million -13.4%3.9%0.8 $2.70 5/28/2021705,700 shares $1.74 million +11.4%4.6%2.9 $2.47 5/14/2021633,500 shares $1.30 million -4.2%N/A1.8 $2.05 4/30/2021661,100 shares $1.44 million -9.7%N/A1.4 $2.17 4/15/2021731,900 shares $1.69 million +16.5%N/A1.2 $2.31 3/31/2021628,000 shares $1.44 million +14.8%N/A0.9 $2.30 3/15/2021547,200 shares $1.41 million +8.2%N/A0.8 $2.57 2/26/2021505,700 shares $1.39 million +7.6%N/A0.8 $2.75 2/12/2021469,800 shares $1.37 million +35.8%N/A0.7 $2.91 1/29/2021346,000 shares $743,900.00 -6.4%N/A0.6 $2.15 1/15/2021369,800 shares $761,788.00 +16.2%N/A0.7 $2.06 12/31/2020318,300 shares $569,757.00 -5.7%N/A0.5 $1.79 12/15/2020337,400 shares $651,182.00 -7.2%N/A0.1 $1.93 11/30/2020363,700 shares $709,215.00 -14.5%N/A0.1 $1.95 11/15/2020425,600 shares $783,104.00 -32.8%N/A0.2 $1.84 10/30/2020633,000 shares $1.13 million +13.2%N/A0.3 $1.79 10/15/2020559,200 shares $1.08 million -9.2%N/A0.2 $1.94 9/30/2020615,500 shares $1.37 million +9.7%N/A0.2 $2.23 9/15/2020561,000 shares $746,130.00 +9.0%N/A0.7 $1.33 8/31/2020514,800 shares $710,424.00 +97.6%N/A0.5 $1.38 8/14/2020260,500 shares $403,775.00 -16.6%N/A0.3 $1.55 7/31/2020312,200 shares $502,642.00 +283.5%N/A0.3 $1.61 7/15/202081,400 shares $108,262.00 +40.8%N/A0.2 $1.33 6/30/202057,800 shares $79,764.00 +72.0%0.6%0.1 $1.38 6/15/202033,600 shares $52,080.00 +309.8%0.4%0.1 $1.55 5/29/20208,200 shares $13,448.00 +110.3%0.1%0 $1.64 5/15/20203,900 shares $5,304.00 -13.3%0.1%0 $1.36 ADIL Short Interest - Frequently Asked Questions What is Adial Pharmaceuticals' current short interest? Short interest is the volume of Adial Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 217,100 shares of ADIL short. 3.36% of Adial Pharmaceuticals' shares are currently sold short. Learn More on Adial Pharmaceuticals' current short interest. Which institutional investors are shorting Adial Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adial Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Adial Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.36% of Adial Pharmaceuticals' floating shares are currently sold short. Is Adial Pharmaceuticals' short interest increasing or decreasing? Adial Pharmaceuticals saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 217,100 shares, a drop of 48.0% from the previous total of 417,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adial Pharmaceuticals' float size? Adial Pharmaceuticals currently has issued a total of 6,575,000 shares. Some of Adial Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adial Pharmaceuticals currently has a public float of 6,460,000 shares. How does Adial Pharmaceuticals' short interest compare to its competitors? 3.36% of Adial Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adial Pharmaceuticals: BriaCell Therapeutics Corp. (5.96%), Allarity Therapeutics, Inc. (11.15%), Lipocine Inc. (1.39%), MIRA Pharmaceuticals, Inc. (3.96%), Cingulate Inc. (4.50%), Upexi, Inc. (5.92%), GlycoMimetics, Inc. (3.34%), Edesa Biotech, Inc. (0.90%), Cocrystal Pharma, Inc. (0.09%), Bullfrog AI Holdings, Inc. (7.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Adial Pharmaceuticals stock? Short selling ADIL is an investing strategy that aims to generate trading profit from Adial Pharmaceuticals as its price is falling. ADIL shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adial Pharmaceuticals? A short squeeze for Adial Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADIL, which in turn drives the price of the stock up even further. How often is Adial Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADIL, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies BCTX Short Interest Data ALLR Short Interest Data LPCN Short Interest Data MIRA Short Interest Data CING Short Interest Data UPXI Short Interest Data GLYC Short Interest Data EDSA Short Interest Data COCP Short Interest Data BFRG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADIL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADIL Stock Free ADIL Stock Alerts